A Thy-1–negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials
Science Advances · 2024
DOI: 10.1126/sciadv.adf2675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Daniel Abebayehu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Schools of Engineering and Medicine, University of Virginia, Charlottesville, VA 22908, USA. Hauptthemen laut MEDLINE: Biocompatible Materials, Fibroblasts, Fibrosis, Hydrogels. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Fibrosis-associated fibroblasts have been identified across various fibrotic disorders, but not in the context of biomaterials, fibrotic encapsulation, and the foreign body response. In other fibrotic disorders, a fibroblast subpopulation defined by Thy-1 loss is strongly correlated with fibrosis yet we do not know what promotes Thy-1 loss. We have previously shown that Thy-1 is an integrin regulator enabling normal fibroblast mechanosensing, and here, leveraging nonfibrotic microporous annealed particle (MAP) hydrogels versus classical fibrotic bulk hydrogels, we demonstrate that Thy1 −/− mice mount a fibrotic response to MAP gels that includes inflammatory signaling. We found that a distinct and cryptic α–smooth muscle actin–positive Thy-1 − fibroblast population emerges in response to interleuklin-1β (IL-1β) and tumor necrosis factor–α (TNFα). Furthermore, IL-1β/TNFα-induced Thy-1 − fibroblasts consist of two distinct subpopulations that are strongly proinflammatory. These findings illustrate the emergence of a unique proinflammatory, profibrotic fibroblast subpopulation that is central to fibrotic encapsulation of biomaterials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Schools of Engineering and Medicine, University of Virginia, Charlottesville, VA 22908, USA.
- Robert Berne Cardiovascular Research Center, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Cell Biology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
ORCID-Profile: Daniel Abebayehu, Blaise N Pfaff, Grace C Bingham, Andrew E Miller, Mathew Kibet, Donald R Griffin, Thomas H Barker
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
Zitieren
APA
Abebayehu, D., Pfaff, B. N., Bingham, G. C., Miller, A. E., Kibet, M., Ghatti, S., Griffin, D. R., & Barker, T. H. (2024). A Thy-1–negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials. Science Advances. https://doi.org/10.1126/sciadv.adf2675
Vancouver
Abebayehu D, Pfaff BN, Bingham GC, Miller AE, Kibet M, Ghatti S, et al. A Thy-1–negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials. Science Advances. 2024. doi:10.1126/sciadv.adf2675
BibTeX
@article{Abebayehu2024,
author = {Abebayehu, Daniel and Pfaff, Blaise N and Bingham, Grace C and Miller, Andrew E and Kibet, Mathew and Ghatti, Surabhi and Griffin, Donald R and Barker, Thomas H},
title = {A Thy-1–negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adf2675}
}
EUVIMED